Introduction
The worldwide market for scallops represents 2.4 million tonnes p.a. of which a very large proportion (66%) derives from aquaculture (FAO Fisheries & Aquaculture Information & Statistics Service 2010) . This large contribution by aquaculture mainly involves on-growing scallops from the wild, as opposed to the dredging of sea beds, which is how the capture fisheries operate. The main countries for scallop aquaculture are China (82% of total aquaculture) and Japan (16%); while Chile, Peru, Canada, Sth. Korea, Russia, Brazil, Ireland, United Kingdom, Norway and Spain also have established industries. With these statistics in mind, it can be seen that there is benefit to be had in many countries from the hatchery production of scallop larvae. Such production would greatly assist the aquaculture-lopsided industry through means that four species of probiotics were able to protect P. maximus larvae against 86 pathogen-challenge by Vibrio spp., under the conditions of a multi-well plate bioassay 87 (Kesarcodi-Watson, Miner, Nicolas & Robert, 2012) . 88
89
When compared with the larvae of other bivalves such as oysters and mussels, P. 90 maximus larvae have proven more difficult to culture successfully (Robert & Gérard, 91 1999; Helm, Bourne & Lovatelli, 2004) ; they appear to be more sensitive to biotic 92 (bacteria) and abiotic factors (tank design/culture technique). The highly variable 93 production output which occurs at present offers risk to the farmer and needs to be 94 improved. To do this, all aspects of scallop larval rearing warrant investigation to find 95 possible areas that allow less variable and improved output. In the present study, 96 bacteriological aspects concerning scallop larval rearing were investigated. Firstly, the 97 effect of the age of scallop larvae upon pathogen susceptibility was investigated. 98
Secondly, the effect of four probiotics was determined during the full larval cycle of 99
scallop. The probiotics were tested both individually and in a multi-strain mix 100 containing all. Each probiotic treatment was tested during routine unchallenged 101 rearing and also against a pathogen-challenge by V. Larvae were treated with antibiotics (chloramphenicol 8ppm); one treatment for the 118 "age as a factor of pathogen susceptibility" study at d2 PF, and two treatments for the 119 probiotic trial, at d2 and d4 PF. The treatments were timed to allow three days to pass 120 before experimental pathogen-challenge. Although now banned for commercial 121 application, chloramphenicol was chosen for the present study as it has been used 122 historically on an experimental basis in P. maximus larviculture with greater success 123 than other antibiotics (Le Pennec, Prieur & Chardi, 1973; Robert, Miner & Nicolas, 124 1996) . Antibiotic treatment, at least once, at the beginning of P. maximus larval 125 rearing is currently imperative. Trials rearing scallop larvae without this initial 126 treatment were not successful, even when probiotics were used (unpublished data); 127 this is believed to be a result of the Vibrio spp., which can be eliminated by this . Water changes of all tanks occurred every two days and larvae were 165 fed at water changes as described previously. A control treatment contained non-166 challenged larvae. All treatments were conducted in triplicate. 167 Young larvae (d5 PF) from the tested cohort were not highly susceptible to V. 226 splendidus with only high levels of V. splendidus (10 6 CFU ml -1 ) resulting in a small 227 mortality increase above those in the control treatment (Table 2) . However, challenge 228 of d5 PF larvae with V. pectenicida resulted in large mortalities at all concentrations 229 (Table 2) . Furthermore, at the smallest pathogen inoculum tested (10 4 CFU ml -1 ) all 230 larvae had died seven days following challenge with V. pectenicida. When d15 larvae 231 were challenged, there was a far greater resistance to V. pectenicida ( (Table 3) . 242
There were occasional statistical differences, yet in terms of absolute percentage 243 larval survivals, these differences were very minor and were not present by the end of 244 the trial (d29). Differences were, however, seen between treatments in terms of larval 245 size (Table 3 ) and the yield of competent larvae (Fig. 1A) . The largest larvae were 246 observed in the control and also those administered A. macleodii 0444 or P. 247 gallaeciensis (Table 3) . Those provided Pseudoalteromonas sp. D41 and the mix of 248 all probiotics grew the slowest. In terms of the competent larvae yields, 249
Pseudoalteromonas sp. D41 and the antibiotic treatment performed worse than the 250 other treatments; the other treatments being statistically no different to each other (Fig.  251   1A) . (Table 4) . These three treatments provided the best protection 262 against pathogen-challenge; yet, administration of A. macleodii 0444, Neptunomonas 263 sp. 0536 and Pseudoalteromonas sp. D41 also provided protection against the 264 challenge when compared with the untreated pathogen-control larvae (Table 4 ). In 265 terms of competent larvae yields reached following pathogen-challenge, P. 266 gallaeciensis and the probiotic-mix performed the best; whereas, the pathogen-control 267
and Pseudoalteromonas sp. D41 did the worst (Fig. 1B) . 268 269 for the animals being cultured; however, we can now say, at least with P. maximus 284 larvae, that larvae which survive the first two weeks of culture are less likely to 285 succumb to pathogenic bacteria. A likely reason why older larvae withstand pathogen-286 challenge better than younger larvae is due to the increased lipid levels that are found increased pathogen resistance in older larvae might be due to the natural resident 296 bacteria which colonize the larvae. A more developed microflora population might 297 offer natural bacterial defenses against pathogens. Indeed, study of other aquatic 298 animals have shown a shift in dominant bacterial groups during the larval cycle 299 (Bergh, Naas & Harboe, 1994) , and perhaps it is the groups which colonize at the later 300 stages which offer enhanced protection against the pathogens. In scallop larvae, 301 bacterial effects have not been studied as highly as lipids; however in the present 302 study we have shown that bacteria have the potential to limit pathogenic effects. It is 303 likely that a natural bacterial population develops in older larvae strengthening them 304 against pathogenic challenges and this is an area which deserves investigation. 305 Probiotic use during this study provided advantages to: larval size, yields of 307 competent larvae, and also in protecting larvae against pathogen-challenge. None of 308 the probiotics tested in this study affected the survival of scallop larvae during routine, 309 unchallenged rearing. During routine rearing, the probiotics P. gallaeciensis and A. 310 macleodii 0444 showed merit by producing both the largest larvae and highest yield 311 of competent larvae. Interestingly, despite the larvae inoculated with Neptunomonas 312 sp. 0536 not being the largest larvae, they achieved the highest absolute yield of 313 competent larvae. The reason for this is unclear, but it is certainly a useful trait. For 314 these reasons, a probiotic mix is probably a good option for future probiotic use. This 315 mix should exclude Pseudoalteromonas sp. D41 which displayed the slowest growth 316 and lowest yield of competent larvae, both being worse than the control larvae. It 317 should be mentioned that a strain of Pseudoalteromonas spp. has been described as an 318 opportunistic pathogen of P. maximus larvae (Sandaa, Brunvold, Magnesen & Bergh, 319 2008) . In the present study, when scallop larvae were challenged with V. pectenicida, 320 the probiotic-mix provided high larval survivals which, along with individual 321 administration of P. gallaeciensis, protected larvae to a level no different to that 322 observed when antibiotic was used. This benefit was also witnessed in the yields of 323 competent larvae, with the probiotic-mix producing the best performing larvae 324 following pathogen-challenge. It appears that during routine rearing, and also as a 325 protective measure against pathogen attack, administration of a mixture of A. 326 macleodii 0444, P. gallaeciensis and Neptunomonas sp. 0536 provides desirable 327 attributes to P. maximus larval rearing. Data from the probiotic-mix were potentially 328 undervalued due the mix incorporating Pseudoalteromonas sp. D41, which was 329 negative to the larvae, and the benefits provided from a revised probiotic-mix could 330 be investigated in the future. (strain B2). The study showed that the probiotics allowed completion of the larval 342 cycle without the need to use antibiotics. Similar to the current study, Ruiz-Ponte et al. 343 (1999) tested P. gallaeciensis upon P. maximus larvae; however, they found that 344 neither pathogen-challenged nor unchallenged larvae were protected by live bacterial 345 cells of P. gallaeciensis. Our findings are in conflict with those of Ruiz-Ponte et al. 346 (1999) ; herein, P. gallaeciensis was the best performing probiotic, providing 347 protection against pathogen attack no different to when antibiotic was used. Ruiz-348
Ponte et al. proposed that perhaps P. gallaeciensis produced substances toxic to the 349 larvae, which were more pronounced at higher levels of P. gallaeciensis, or that 350 perhaps the organic matter introduced with higher levels of P. gallaeciensis aided in 351 pathogen proliferation. If true, these could potentially explain the differences in their 352 results and those in the current study because they administered P. gallaeciensis at 10 6 353 CFU ml -1 whereas 10 4 -10 5 CFU ml -1 was used in the current study. Additionally, the 354 ambient bacterial community would most certainly have been different between the 355 present study and that of Ruiz-Ponte et al. (1999) ; and this also might have influenced 356 the effect of probiotic addition. 357
358
One conspicuous aspect of current P. maximus larviculture is the use of antibiotics in 359 the early stages. Trials conducted with/without two doses of chloramphenicol (at d3 360 and d4 PF), using the same batch of larvae, showed that those not provided the 361 antibiotic underwent large mortality whilst those provided the antibiotic did not (A. 362 Kesarcodi-Watson, unpublished data). This is a regular occurrence with P. maximus 363 larvae (Robert et al., 1996; Torkildsen, Lambert, Nylund, Magnesen & Bergh, 2005) 364 and it appears the Vibrio spp. which are present in these early stages (detected by 365 culture on TCBS agar plates) need to be eliminated by antibiotics to allow scallop 366 larvae to proceed successfully. Furthermore, because best efforts are made to sterilize 367 larval rearing waters (1 µm filtered, U.V. sterilized) yet Vibrio spp. still occur in early 368 larval rearing waters, it appears that these bacteria enter P. maximus larval rearing 369 systems via vertical transmission from the broodstock (Holbach, PhD in prep), also 370 put forward for Chilean scallop, Argopecten purpuratus (Riquelme, Hayashida, 371
Toranzo, Vilches & Chavez, 1995) . 372 antibiotics (Andersen, Burnell & Bergh, 2000; Torkildsen & Magnesen, 2004; 376 Magnesen et al., 2006; Andersen et al., 2013) . During this work, a very low water 377 turn-over (approximately one tank exchange per day) and low density of larvae (3.0-378 5.2 larvae ml -1 starting density, with a final density at settlement of 1.0 larvae ml -1 ) 379 were used (Magnesen et al., 2006 , Andersen et al., 2013 . The work in Norway lays a 380 good foundation to antibiotic-free scallop larviculture (in an industry with increasing 381 restrictions on antibiotic use), but with such low water exchange it currently remains a 382 slightly more intensive version of a batch-culture system; improvements in stocking 383 density and water-flow would be desirable to provide efficient larval rearing. Table 2 . Scallop larvae survival (% ± S.E.) after two separate pathogen-challenges with a range of concentrations. During the first challenge, V. pectenicida or V. splendidus was used. During the second challenge only V. pectenicida was used. Each challenge used the same cohort of larvae, although different ages of the larvae (i.e. d5 or d15). Values in a column with an asterix (*) are statistically different to the unchallenged control (p < 0.05). 
